You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Scalable MXene Synthesis for Aerospace Applications
SBC: BALLYDEL TECHNOLOGIES INC. Topic: AF21ATCSO2During the Phase II effort, Ballydel Technologies will develop scalable and safe processes for the manufacture of MAX phase and MXene powders in 1Kg batch sizes. Additionally, our team will implement commercial-scale mixing procedures for the production
STTR Phase II 2023 Department of DefenseAir Force -
Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention
SBC: FORTISCIENCE, INC. Topic: NHLBIProject Summary Project Title: Development of a Small Molecule Inhibitor of Fortilin for Atherosclerosis Treatment and Prevention. Atherosclerosis affects more than 18 million Americans and is a major cause of cardiovascular diseases and acute cardiovascular events, such as heart attack and stroke. Current interventions include changes to diet and exercise, smoking cessation, and treatment with st ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Amino Acids and Pediatric Hepatic Steatosis
SBC: THE AMINO COMPANY LLC Topic: 3007. Project Summary/Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in North America (1). Hepatic steatosis (HS) is the hallmark of NAFLD (2). NAFLD may transition in sub-groups to chronic inflammation (non- alcoholic steatohepatitis, NASH), and ultimately to cirrhosis. HS is prevalent in all stages of NAFLD. 3-10% of all children in the US and 40-70% of obese ch ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
PET Imaging of Damaging Neuroinflammation in Alzheimer's Disease
SBC: EINSENCA INC. Topic: NIAAlzheimer's disease (AD) is a devastating and progressive disease without a cure. Neuroinflammation is now recognized as a key early event in the development of AD. Aberrant neuroinflammatory response activates immune cells that can increase oxidative stress, and oxidative stress can directly damage neurons and axons, cause demyelination, and break down the blood-brain barrier (BBB). Thus, damagin ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Rapid Deploy CUI Development Environments for Dev Team
SBC: SHE BASH LLC Topic: AF231D012The Technical Problem: The Air Force Nuclear Weapons Center (AFNWC) and the broader Department of Defense (DOD) require operational agility that can only be achieved through the implementation of Software Defined Weapon Systems. In today's modern systems,
SBIR Phase II 2023 Department of DefenseAir Force -
Thermavent-SD Munitions Lifting Assembly Sunshade Cover
SBC: MOONPRINT SOLUTIONS LLC Topic: N211024The munitions lifting assembly sunshade cover (Thermavent-SD) is a lightweight Static Dissipative (SD) cover system for use on the A/E32K-11 Munitions Lifting Assembly (MLA). It is designed to provide >70% solar radiation blockage while functioning in a wide range of environments consistent with military operations. The Thermavent-SD cover will be designed to be authorized for use by the Naval ...
SBIR Phase II 2023 Department of DefenseNavy -
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
SBC: INOVODEL, INC. Topic: NHLBISUMMARY Patients with pulmonary hypertension (PH) experience low oxygen saturation, shortness of breath, low quality of life, and a short life span (lt10 years) following diagnosis. These patients frequently present to emergency rooms, and many are admitted to intensive care units (ICUs), straining the health care system. Despite therapy with phosphodiesterase-5 inhibitors, prostacyclin analogs, a ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
ATAK Smart Garments for Automatic Wound Detection (Shot, Shrapnel, Cut) and Treatment
SBC: LEGIONARIUS LLC Topic: A224017Redacted.
SBIR Phase II 2023 Department of DefenseArmy -
Advanced Superlattice LED System (ASLEDS)
SBC: Chip Design Systems Inc. Topic: MDA21018Single-color MWIR LED arrays have made steady progress in demonstrating good performance, operability, efficiency, and reliability. On the other hand, dual-color MWIR LED arrays are highly desirable for testing dual color sensors. Compared to the optical combining approach, native dual-color LED arrays offer many benefits, including reduced system size and simpler optical system design. The propos ...
SBIR Phase II 2023 Department of DefenseMissile Defense Agency -
AI Assistance for Derivative Classification and Redaction
SBC: CONDUCTORAI CORPORATION Topic: AFX236DPCSO1Classifying and marking documents in the Department of Defense is largely a manual process. Manual classification is challenging, time-consuming, resource-intensive, and sometimes inconsistent. Recent advancements in AI and large language models (LLMs) ar
SBIR Phase II 2023 Department of DefenseAir Force